HomeORGANIZATION
ORGANIZATION

JMA’s Nakagawa Questions Price Difference for LLPs and AGs, Negative about PhRMA Pitch for AWP Alternatives
(Jun.9.2017)

JMA Vice President Toshio Nakagawa
Toshio Nakagawa, vice president of the Japan Medical Association (JMA) and a vocal member of a key reimbursement policy panel, is raising a question over the price difference between long-listed products (LLPs), or off-patent brand-name drugs, and authorized generics (AGs) that are identical to LLPs ...
(LOG IN FOR FULL STORY)

News Calendar